COMPANY
AmMax Bio
AmMax Bio is a clinical-stage biotechnology company leveraging its expertise to discover and develop antibody drug conjugates (ADCs), often with clinically validated components, to treat various cancers. From company website Source · Oct 12, 2026
Timeline
- Partnership Partnership / licensing announced Jun 9, 2026. Source: company's own press page. source ↗
Funding
- Partnership / licensing announced Jun 9, 2026. Source: company's own press page. source ↗